drugset / Trial / NCT01377415

Continuous Subacromial Bupivacaine

NCT01377415 ↗

Completed 90 enrolled Turku University Hospital
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The investigators wanted to re-evaluate the effects of subacromial bupivacaine infusion after shoulder arthroscopy with standard surgical techniques, including rotator cuff operations. The investigators hypothesized that patients having 5.0 mg/ml bupivacaine infusion at a rate of 2 ml/h subacromially would need less opioids than patients receiving a placebo infusion.

Timeline

Start
2009-01
Primary completion
2010-06
Completion
2010-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Bupivacaine Other / unclassified 5 mg/ml Other

Indications

No indication recorded.